August 11, 2017 Share

BioNJ’s 5th Annual CEO Summit (Oct 27)

BioNJ’s 5th Annual CEO Summit will bring together life sciences C-suite leaders and their teams — representing a wide breadth of companies from early to late stage, as well as public, private, revenue and pre-revenue enterprises — for a full-day program focused on the opportunities and challenges facing the future of medical innovation. You’ll hear from thought leaders including Mark Alles, CEO, Celgene; Albert Bourla, Group President, Pfizer Innovative Health, Pfizer Inc.; Dr. Elizabeth Fowler, Vice President, Global Health Policy, Johnson & Johnson; James Greenwood, President & CEO, BIO; Paris Panayiotopoulos, Former President & CEO, ARIAD Pharmaceuticals; Paul Hudson, CEO, Novartis; Dr. Clive Meanwell, CEO, The Medicines Company and Brent Saunders, Chairman & CEO, Allergan.





This post will expire at 8:28pm on Friday October 27th, 2017